How to Design Efficiency into Peptide Processes from Day One

	Drug Discovery
	The latest drug discovery news from News Medical

Discover how it is possible to turn peptide R&D and scaling up challenges into competitive advantages! In this article, you will learn how integrated analytics and sustainability practices support you in optimizing solvent use, preventing scale-up delays, and meeting ESG goals. Transform early decisions into seamless GMP transitions.

			FDA grants approval to begin Phase I clinical trials of heart tissue regeneration drug AD-NP1 The body's tissues can get injured in many ways, but while some injuries heal perfectly, others don't heal at all. A cut in the skin, for example, usually heals all on its own, while internal organs, such as the heart after a heart attack or the kidney after an acute injury, remain damaged, leading to diminished function.

			Studies Uncover PAR2 Receptor’s Role in Gut Inflammation and Pain Abdominal pain is common in a variety of digestive diseases, including inflammatory bowel disease and irritable bowel syndrome.

	Breakthrough in RNA-targeted drug discovery offers hope against viral diseases In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus that causes COVID-19.

	AI, omics, and systems biology could transform heart drug development AI, omics, and systems biology can now help scientists design targeted drugs for cardiovascular disease pathways once thought "untreatable."

	Whole genome sequencing may guide care for thousands of breast cancer patients Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over 15,000 women a year, say scientists at the University of Cambridge.

	New ASPIRE trial tests chemotherapy combination for advanced prostate cancer The Alliance for Clinical Trials in Oncology has launched the ASPIRE trial-a large-scale, Phase III clinical study investigating whether adding chemotherapy to current standard treatments can extend survival for men living with advanced prostate cancer.

	Moffitt awarded $22.4 million grant to lead novel studies and clinical trials for leptomeningeal disease Researchers at Moffitt Cancer Center have been awarded a $22.4 million grant from the U.S. Department of War to lead groundbreaking studies and clinical trials for leptomeningeal disease, a devastating complication of breast and other cancers that spreads to the coverings of the brain and spinal cord.

	New dual-target vaccine shows promise against typhoid and Salmonella Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.

How would you rate today's newsletter?

Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025